| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81.4B | $78.8B | $19.7B | $19.0B | $16.1B | $8.9B | $15.5B | — |
| Cost of Revenue | $66.4B | $64.2B | $16.0B | $15.5B | $13.2B | $7.3B | $12.5B | — |
| Gross Profit | $15.0B | $14.6B | $3.7B | $3.4B | $2.9B | $1.6B | $3.0B | $2.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.1B | $3.2B | $1.0B | $0.8B | $0.6B | $-0.5B | $0.7B | $0.7B |
| Net Income | $1.8B | $2.0B | $0.7B | $0.5B | — | — | — | — |
| EPS (Basic) | $3.74 | $3.90 | $1.45 | $1.00 | $0.29 | $-1.22 | $1.04 | $0.86 |
| EPS (Diluted) | $3.73 | $3.89 | $1.44 | $0.99 | $0.29 | $-1.22 | $1.03 | $0.85 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.8B | $24.9B | $22.8B | $22.1B | $21.4B | $22.6B | $18.0B | $18.1B |
| Current Assets | $12.0B | $11.0B | $10.6B | $10.5B | $10.7B | $12.3B | $8.1B | $8.0B |
| Cash & Equivalents | $1.1B | $0.7B | $0.7B | $0.9B | $3.0B | $6.1B | $0.5B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.9B | $9.2B | $8.5B | $8.8B | $7.3B | $6.7B | $6.1B | $6.6B |
| Stockholders' Equity | $1.8B | $1.9B | $2.0B | $1.4B | $1.6B | $1.2B | $2.5B | $2.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $3.0B | $2.9B | $1.8B | $1.9B | $1.6B | $2.4B | $2.2B |
| Investing Cash Flow | $-0.7B | $-2.0B | $-0.8B | $-1.9B | $-0.4B | $-0.8B | $-0.7B | $-0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.4B | $-1.0B | $-2.1B | $-2.0B | $-4.6B | $4.7B | $-1.8B | $-1.4B |